Principal Investigator Erica James
Principal Investigator Kevin Esvelt
Principal Investigator James Collins
Principal Investigator Michael Cima
Principal Investigator M Toksöz
Principal Investigator Deborah Lucas
Principal Investigator Caroline Uhler
In response to new business models, accelerated timelines, and unforeseen market dynamics, healthcare companies are seeking to innovate rapidly and effectively to meet new challenges. A key criterion for success is the adoption of cutting-edge tools that derisk and accelerate the drug development process. Investment in these tools pays dividends across a company's pipeline.